Sialanar for Drooling in CP Children Headed to Okay in EU
The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) recommended the approval of Proveca’s Sialanar (glycopyrronium bromide) for the treatment of severe drooling in children and adolescents with neurological disorders, such as cerebral palsy. Children with cerebral palsy and other motor or neurological disorders…